
How can we help you?
Let us explore how our Phoenix solutions can optimize your organization’s operational efficiency.

1. PKAssist is a legacy version of the wokflow automation tool PKSubmit.
Contact us
Transform your drug development journey with Certara’s comprehensive solutions. From molecule to market, we seamlessly integrate science, technology, strategic and regulatory expertise to solve your unique challenges.
Discover moreUnify insights to accelerate drug development and achieve development milestones. Partner with Certara to unlock your pipeline’s potential.
Learn moreCertara’s software solutions offer transformative approaches across all drug development phases, aligning with recognized industry standards. By integrating advanced modeling, analytics, and automation, they break down silos, streamline workflows, and drive regulatory success.
View allTransform drug development with our tailored services. From predictive modeling to market access strategies, Certara’s integrated services enhance decision-making, streamline processes, and make your drug a safer bet.
View allCertara tailors solutions for biotech, pharma, and CROs, addressing unique challenges to drive success.
Learn who we work withCertara collaborates with leading biotech, pharma, and CRO partners to tackle complex challenges, deliver innovation, and shape the future of healthcare.
Learn moreWith over 1,000 articles spanning categories and solutions, Certara’s resources is a geek haven. It’s all here—built for scientists who dare to think different.
View allWith over 1,550+ employees in more than 30 countries, over 28% of which have PhDs, our vision is to transform drug development for good.
Learn more about usJoin a global leader transforming the future of drug development. Explore opportunities to innovate, grow, and make a difference in transforming lives.
Visit careers siteHome / Case Study / Enhancing Pharmacokinetics Workflows at Charles River
Charles River, a global leader in drug development, sought to improve its pharmacokinetics (PK) analysis across its seven worldwide sites. With each site using its own systems, workflows, and procedures, the company recognized the opportunity to optimize consistency in PK analysis and reporting. By centralizing efforts and refining processes, Charles River aimed to enhance scientific methodologies, improve data handling practices, and ensure continued adherence to the highest standards of regulatory compliance.
The company’s existing systems were becoming less efficient and lacked seamless integration. With multiple versions of Certara’s Phoenix platform in use, documenting compliance with 21 CFR Part 11 was becoming time-consuming. Additionally, the absence of a unified and secure repository for PK data led to teams spending excessive time searching for data and demonstrating compliant data provenance – time better spent on the precise and well-contextualized analysis on which Charles River has built its reputation
They required a solution that could ensure uniformity across all sites, while maintaining the flexibility to handle varied client demands, complex study designs, and different regulatory frameworks such as FDA requirements in the U.S. and OECD guidelines in Europe.
Charles River implemented a global, integrated platform to centralize and automate their PK analysis processes. This solution was built on a three-pronged approach, utilizing multiple Certara solutions to address their diverse needs.
Charles River relies on Phoenix as its core analytical tool for generating PK parameters. With this Phoenix, teams standardized their reporting methods, ensuring that all global sites provided the same high-quality, compliant output.
By pulling data directly from Phoenix and other software into the secure, cloud-based repository Integral, Charles River eliminated inefficiencies and ensured data integrity. Integral serves as the central data repository for PK information, providing scalable storage and ensuring compliance with data security regulations.
PKAssist1, a customized tool developed in collaboration with Certara, replaced the cumbersome, manual workflows with a more automated, efficient system. This tool proved especially helpful in automating the generation of SEND datasets, ensuring that non-clinical data was processed and analyzed consistently across all global sites.
The implementation of this global PK platform has positioned Charles River for continued growth and success in the drug development industry. The ability to harmonize and automate processes across multiple global sites has greatly improved efficiency. Researchers can now access data from any site in real-time, enhancing scientific oversight and ensuring continuity across research programs.
Looking ahead, Charles River plans to further optimize this platform by moving more functions to a cloud-hosted environment, leveraging REST API integrations, and exploring artificial intelligence (AI) applications to further enhance data processing and PK analysis. These advancements will increase flexibility and enable the company to better meet the demands of a rapidly evolving industry.
The result is a single, secure global PK database at Charles River that ensures regulatory compliance for both production and computer systems, while guaranteeing data integrity and change control. This enables the company to implement more secure, compliant, and efficient workflows.
Throughout the implementation, the collaboration with Certara played a pivotal role. They provided ongoing support, not just during the initial setup and deployment, but also throughout production, ensuring that the system continued to meet Charles River’s evolving needs.
Let us explore how our Phoenix solutions can optimize your organization’s operational efficiency.
1. PKAssist is a legacy version of the wokflow automation tool PKSubmit.
Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.
© 2025 Certara. All Rights Reserved. | Privacy policy